Financhill
Back

10x Genomics Vs. Novo Nordisk AS Industry Stock Comparison

Sell
38

TXG
10x Genomics

Last Price:
$14.69
Seasonality Move:
-7.11%
Sell
26

NVO
Novo Nordisk AS

Last Price:
$87.33
Seasonality Move:
6.58%
Sell
38
10x Genomics (TXG) is a Sell

Is 10x Genomics a Buy, Sell or Hold?

  • The current 10x Genomics [TXG] share price is $14.73. The Score for TXG is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • TXG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $88.71. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TXG Stock Price Chart

What is 10x Genomics's stock price today?

  • The 10x Genomics share price today is $14.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TXG is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $88.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

TXG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.41 Sell
Relative Strength Index (14 RSI): 47.58 Sell
Chaikin Money Flow: 1440164 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.83 - 15.91) Sell
Bollinger Bands (100): (15.01 - 21.71) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.52 Sell
Relative Strength Index (14 RSI): 27.28 Sell
Chaikin Money Flow: 14079249 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.16 - 111.42) Sell
Bollinger Bands (100): (106.53 - 131.27) Sell

TXG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.33 Buy
20-day SMA: 15.21 Sell
50-day SMA: 15.3 Sell
200-day SMA: 22.3 Sell
8-day EMA: 14.47 Buy
20-day EMA: 14.88 Sell
50-day EMA: 15.92 Sell
200-day EMA: 23.18 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.84 Sell
20-day SMA: 105.84 Sell
50-day SMA: 108.65 Sell
200-day SMA: 126.03 Sell
8-day EMA: 99.1 Sell
20-day EMA: 103.93 Sell
50-day EMA: 109.19 Sell
200-day EMA: 117.8 Sell

10x Genomics Earnings Growth & TXG Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.05 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.66 per share.

10x Genomics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):